PDT Partners’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,875
| Closed | -$89K | – | 931 |
|
|
2021
Q3 | $89K | Buy |
2,875
+1,302
| +83% | +$40.3K | 0.01% | 738 |
|
|
2021
Q2 | $51K | Sell |
1,573
-5,760
| -79% | -$187K | ﹤0.01% | 773 |
|
|
2021
Q1 | $277K | Buy |
7,333
+2,693
| +58% | +$102K | 0.02% | 636 |
|
|
2020
Q4 | $220K | Sell |
4,640
-841
| -15% | -$39.9K | 0.01% | 601 |
|
|
2020
Q3 | $177K | Buy |
5,481
+2,561
| +88% | +$82.7K | 0.01% | 642 |
|
|
2020
Q2 | $129K | Sell |
2,920
-273
| -9% | -$12.1K | 0.01% | 619 |
|
|
2020
Q1 | $105K | Buy |
3,193
+1,633
| +105% | +$53.7K | 0.01% | 611 |
|
|
2019
Q4 | $80K | Sell |
1,560
-2,160
| -58% | -$111K | ﹤0.01% | 697 |
|
|
2019
Q3 | $137K | Hold |
3,720
| – | – | 0.01% | 426 |
|
|
2019
Q2 | $206K | Buy |
+3,720
| New | +$206K | 0.01% | 364 |
|
|
2015
Q3 | – | Sell |
-13
| Closed | -$28K | – | 1389 |
|
|
2015
Q2 | $28K | Hold |
13
| – | – | ﹤0.01% | 1311 |
|
|
2015
Q1 | $30K | Hold |
13
| – | – | ﹤0.01% | 1343 |
|
|
2014
Q4 | $27K | Sell |
13
-7
| -35% | -$14.5K | ﹤0.01% | 604 |
|
|
2014
Q3 | $40K | Hold |
20
| – | – | ﹤0.01% | 1257 |
|
|
2014
Q2 | $71K | Buy |
20
+4
| +25% | +$14.2K | ﹤0.01% | 1376 |
|
|
2014
Q1 | $60K | Hold |
16
| – | – | ﹤0.01% | 1287 |
|
|
2013
Q4 | $53K | Buy |
16
+3
| +23% | +$9.94K | 0.01% | 615 |
|
|
2013
Q3 | $54K | Buy |
+13
| New | +$54K | ﹤0.01% | 1464 |
|